Riskpilot← Back to searchSign inGet full accessSKINTECH AS
ASActiveOrg 994507281Lilleakerveien 8, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20090 employees
Revenue 2024
NOK 17,6M
-8% vs 2023
EBITDA margin
-5.7%
-205% vs 2023
Equity ratio
20.6%
Financial strength
Net profit 2024
NOK -825K
-229% vs 2023
| Revenue | NOK 17,6M | -8% |
| EBITDA | NOK -994K | -205% |
| Net profit | NOK -825K | -229% |
| Total assets | NOK 12M | +3% |
| Equity | NOK 2,5M | -25% |
| Employees | 0 | — |
Legal name
SKINTECH AS
Org number
994507281
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. september 2009
Share capital
NOK 330 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Import, distribusjon og salg av teknisk medisinsk utstyr til sykehus og private klinikker samt salg av kosmetiske produkter og annet som står i naturlig forbindelse med dette.
Address
Lilleakerveien 8, 0283 Oslo
Email
support@skintech.in
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 226 | 7 114 | 11 250 | 11 570 | 12 194 | 16 253 | 13 352 | 14 058 | 15 023 | 16 744 | 12 211 | 25 108 | 25 203 | 19 124 | 17 588 |
| Staff expenses | −0 | −709 | −1 897 | −2 408 | −2 650 | −1 995 | −2 104 | −2 098 | −1 994 | −2 552 | −2 317 | −3 688 | −2 860 | −40 | −22 |
| EBITDA | −140 | 1 392 | 1 322 | −171 | −633 | 714 | 701 | 349 | 1 520 | 648 | −748 | 6 422 | 5 491 | 949 | −994 |
| Depreciation & amort. | −0 | −0 | −0 | −1 | −4 | −4 | −16 | −27 | −40 | −4 | −9 | −27 | −26 | −20 | −0 |
| EBIT | −140 | 1 392 | 1 322 | −172 | −637 | 710 | 685 | 322 | 1 480 | 645 | −757 | 6 395 | 5 465 | 928 | −994 |
| Net financials | 0 | −47 | −27 | −56 | −93 | 25 | −49 | −146 | −107 | −91 | −357 | −157 | −77 | −93 | −62 |
| Profit before tax | −140 | 1 345 | 1 296 | −228 | −730 | 735 | 636 | 176 | 1 374 | 554 | −1 114 | 6 238 | 5 388 | 835 | −1 056 |
| Tax | −39 | 382 | 378 | −43 | −195 | 227 | 164 | 47 | 325 | 128 | −244 | 1 422 | 1 201 | 194 | −231 |
| Net profit | −101 | 963 | 918 | −185 | −535 | 508 | 472 | 129 | 1 049 | 426 | −869 | 4 816 | 4 187 | 642 | −825 |
| Item | 2009 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 751 | 4 496 | 6 553 | 6 661 | 5 858 | 4 288 | 4 030 | 6 692 | 7 713 | 7 617 | 7 265 | 12 652 | 11 814 | 11 592 | 11 953 |
| Equity | 199 | 1 199 | 2 117 | 1 932 | 1 396 | 1 904 | 2 376 | 2 506 | 3 435 | 3 848 | 2 979 | 2 705 | 2 650 | 3 291 | 2 466 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 551 | 3 297 | 4 436 | 4 730 | 4 462 | 2 384 | 1 653 | 4 186 | 4 279 | 3 769 | 4 286 | 9 947 | 9 164 | 8 301 | 9 487 |
| Total debt | 551 | 3 297 | 4 436 | 4 730 | 4 462 | 2 384 | 1 653 | 4 186 | 4 279 | 3 769 | 4 286 | 9 947 | 9 164 | 8 301 | 9 487 |
EBITDA margin
-5.7%
This company
15.8%
Market median
-136% vs market
20092024
Equity ratio
20.6%
This company
38.2%
Market median
-46% vs market
20092024
Return on equity
-33.4%
This company
18.4%
Market median
-282% vs market
20092024
Net profit margin
-4.7%
This company
8.1%
Market median
-158% vs market
20092024
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20092024
Debt / equity
3.85×
This company
0.62×
Market median
-521% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TT Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Mediq Norge As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mediq Norge As
SKINTECH AS Board members of SKINTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Tronstad Sakshaug | Chief Executive Officer | 0 companies |
| Joachim Warnberg | Chairman | 0 companies |
| Trond Dahl Hansen | Chairman | 0 companies |